Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Atlantic Equities Maintains Neutral on AbbVie, Lowers Price Target to $162

Atlantic Equities analyst Steve Chesney maintains AbbVie (NYSE:ABBV) with a Neutral and lowers the price target from $178 to $162.

byBenzinga Newsdesk

August 1, 2022

1 minute read

Atlantic Equities analyst Steve Chesney maintains AbbVie (NYSE:ABBV) with a Neutral and lowers the price target from $178 to $162.

SIGA Technologies Q2 Sales $8.70M Down From $40.35M YoY

By Michael Horton

Today, 8:47 AM

SIGA Technologies (NASDAQ:SIGA) reported $8.70 million in sales this quarter. This is a 78.44 percent decrease over sales of $40.35 million the same period last year.

SIGA

Missfresh Q2 Adj. EPS $2.91, Sales $293.40M

By Benzinga Newsdesk

Today, 8:47 AM

Missfresh (NASDAQ:MF) reported $293.40 million in sales this quarter.

Analyst Ratings

9 Analysts Have This to Say About Honeywell Intl

By Benzinga Insights

Today, 8:47 AM

Within the last quarter, Honeywell Intl (NASDAQ:HON) has observed the following analyst ratings:

HON

Creatd Shares Volatile Following Recent Press Release From Co. Nasdaq Hearings Panel Gave Decision To Permit Continued Listing Of Co.’s Shares

By Benzinga Newsdesk

Today, 8:47 AM

Creatd, Inc. (Nasdaq CM: CRTD) ("Creatd" or the "Company"), a creator-first holding company, today announced that it has received the decision of the Hearings Panel (the "Panel") of The

CRTD

Atlantic Equities Maintains Neutral on AbbVie, Lowers Price Target to $162

Related Posts

SIGA Technologies Q2 Sales $8.70M Down From $40.35M YoY

Missfresh Q2 Adj. EPS $2.91, Sales $293.40M

9 Analysts Have This to Say About Honeywell Intl

Creatd Shares Volatile Following Recent Press Release From Co. Nasdaq Hearings Panel Gave Decision To Permit Continued Listing Of Co.’s Shares